Inventprise
WA - RedmondBiotechnology
Focus: Inventprise is a vaccine-focused biotechnology company headquartered in Redmond, WA, developing next-generation vaccines for infectious diseases including pneumococcal disease and Group B Streptococcal infections. The company operates at mid-scale (51-200 employees) with a lean pipeline in early-to-mid clinical stages.
Profile data last refreshed 12h ago · AI intelligence enriched 2w ago
Employees
51-200
Open Jobs
0
About Inventprise
AI assessmentNot HiringNo open roles listed right now. Follow Inventprise to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Inventprise's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
5 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
IVT PCV-25
Pneumococcal VaccinesClinical Trials (1)
NCT05540028Study to Evaluate a 25-Valent Pneumococcal Conjugate Vaccine
Phase 1Help build intelligence for Inventprise
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.